Hebang Biotech: Feasibility analysis report on the use of capital raised by Sichuan Hebang Biotechnology Co., Ltd. publicly issued convertible corporate bonds

SZSI · Oct 28, 2022 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.